Risk of Persistent Growth Impairment after Alternate-Day Prednisone Treatment in Children with Cystic Fibrosis
Open Access
- 23 March 2000
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (12) , 851-859
- https://doi.org/10.1056/nejm200003233421204
Abstract
It is uncertain whether the growth impairment that occurs in children during long-term treatment with glucocorticoids persists after the medication is discontinued and ultimately affects adult height.Keywords
This publication has 32 references indexed in Scilit:
- Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: A double-blind comparison of once-daily versus twice-daily administrationThe Journal of Pediatrics, 1998
- Linear growth in prepubertal children with atopic dermatitisArchives of Disease in Childhood, 1998
- Alterations in Growth and Body Composition During Puberty: III. Influence of Maturation, Gender, Body Composition, Fat Distribution, Aerobic Fitness, and Energy Expenditure on Nocturnal Growth Hormone ReleaseJournal of Clinical Endocrinology & Metabolism, 1998
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- A meta-analysis of the effect of oral and inhaled corticosteroids on growthJournal of Allergy and Clinical Immunology, 1994
- Effects of social class, sex, and region of residence on age at death from cystic fibrosis.BMJ, 1989
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.Thorax, 1986
- Bronchial hyperreactivity in cystic fibrosis and asthmaThe Journal of Pediatrics, 1978
- Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.Archives of Disease in Childhood, 1968